Literature DB >> 8371652

Survey of NCAA institutions concerning HIV/AIDS policies and universal precautions.

C A McGrew1, R W Dick, K Schniedwind, P Gikas.   

Abstract

Attention has recently been focused on issues concerning HIV disease and competitive athletics. These issues have included HIV testing of athletes, participation by HIV-infected athletes, and the practice of "Universal Precautions" by members of the athletic health care team. A survey of all NCAA member institutions was conducted to further investigate these areas. Routine testing for the HIV virus is rare in NCAA member athletic departments. Policies of NCAA member institutions athletic departments concerning participation with HIV virus are few but nearly half restrict participation. Only 12 schools reported having HIV-positive athletes or AIDS-diagnosed athletes at their institutions. There is a need for increased awareness, knowledge, and practice of "Universal Precautions" in all athletic training rooms.

Entities:  

Mesh:

Year:  1993        PMID: 8371652

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  5 in total

1.  Proportion of US congregations that have people living with HIV.

Authors:  Steven M Frenk; Mark Chaves
Journal:  J Relig Health       Date:  2012-06

2.  Athletic Trainers as HIV/AIDS Educators for Athletes.

Authors:  B P Hunt; T J Pujol
Journal:  J Athl Train       Date:  1994-06       Impact factor: 2.860

3.  A Model for a Policy on HIV/AIDS and Athletics.

Authors:  L A Bitting; C A Trowbridge; L E Costello
Journal:  J Athl Train       Date:  1996-10       Impact factor: 2.860

4.  National Collegiate Athletic Association Injury Surveillance System commentaries: introduction and methods.

Authors:  Randall Dick; Julie Agel; Stephen W Marshall
Journal:  J Athl Train       Date:  2007 Apr-Jun       Impact factor: 2.860

5.  Pamphlet on HIV and athletes dispels myths about possibility of infection through sports.

Authors:  S Newman
Journal:  CMAJ       Date:  1993-11-01       Impact factor: 8.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.